The rare presentations of a large polyp and an esophageal carcinoma in heterotropic gastric mucosa: a case series

<p>Abstract</p> <p>Background</p> <p>Heterotopic gastric mucosa (HGM) is commonly seen in the upper esophagus during endoscopyand is generally considered a benign disease. A hyperplastic polyp and an adenocarcinoma arising in heterotopic gastric mucosa are quite rare occurences.</p> <p>Case presentations</p> <p>We present two cases: The first is a patient who suffered from dysphagia because of a large hyperplastic polyp that arose from HGM; the polyp was excised endoscopically. Secondly, we report a rare case of adenocarcinoma arising in HGM of the cervical esophagus.</p> <p>Conclusion</p> <p>Morphologic changes or malignant transformation can develop in the inlet patch. Therefore, gastroenterologists should be aware of the possibility of HGM just distal to the upper esophageal sphincter.</p

Cerebral sinus thrombosis in a patient with active ulcerative colitis and double heterozygosity for Factor V Leiden and prothrombin gene mutations

Degertekin, Bulent/0000-0002-7931-7080WOS: 000266113200018PubMed: 19439852Inflammatory bowel diseases are associated with increased risk for thrombotic complications, In patients with ulcerative colitis (UC) cerebral sinus venous thrombosis (CSVT) is an extremely rare complication. We report a patient with active UC and CSVT. The patient was heterozygous for Factor V Leiden and G20210A prothrombin gene mutations without other identifiable precipitating factors. This patient highlights the need for investigating the patients with UC with thrombotic complications for other thrombophilic states

Cerebral sinus thrombosis in a patient with active ulcerative colitis and double heterozygosity for Factor V Leiden and prothrombin gene mutations

Inflammatory bowel diseases are associated with increased risk for thrombotic complications, In patients with ulcerative colitis (UC) cerebral sinus venous thrombosis (CSVT) is an extremely rare complication. We report a patient with active UC and CSVT. The patient was heterozygous for Factor V Leiden and G20210A prothrombin gene mutations without other identifiable precipitating factors. This patient highlights the need for investigating the patients with UC with thrombotic complications for other thrombophilic states

Compilation of a GIS based high spatially and temporally resolved emission inventory for the greater Istanbul area

AbstractEmission inventories are a fundamental input to atmospheric chemical transport models (CTMs). As the latter become increasingly demanding, modern inventories began to provide much more information (high spatial and temporal disaggregation, more chemical compounds etc). In this study we present a computational approach, an emission processing kernel that is used to compile a high spatially and temporally resolved emission inventory for the anthropogenic sources covering the Greater Istanbul Area (GIA) for the reference year 2007. The emission processor is used to produce emissions for a 92x57km area covering the GIA with 2km grid resolution. The emission inventory has high temporal resolution, covering monthly, weekly and diurnal processing and includes CO, NOx, SOx, NH3, and chemically speciated PM10, PM2.5 and NMVOCs emissions. PM10 and PM2.5 are chemically split into organic carbon, elemental carbon, sulfates, nitrates, ammonium and other particles while NMVOCs are chemically speciated into 23 chemical compounds. The compilation process includes the use of various activity information and statistical data that were gathered from local official authorities and experts, measurements, published studies for the region or extracted from pre–existing databases. The results indicate that the road transport sector is the main contributor to the emissions in the area, whereas residential combustion (for SOx) and solvent use (for NMVOCs) are also important source categories. Industrial combustion is found out to be the main SOx emitter. The temporal calculations show that monthly distributions follow the seasonal variation for most of the pollutants with higher emissions in winter time. Diurnal calculations show that the profile fits with the rush hours due to the highest contribution of traffic emissions

Influence of H pylori on plasma ghrelin in patients without atrophic gastritis

AIM: To determine the association between H pylori infection and serum ghrelin levels in patients without atrophic gastritis

AN UNUSUAL PRESENTATION OF INTRAHEPATIC ARTERIOPORTAL FISTULA WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

WOS: 000391179400012Arterioportal fistula (APF) is a rare disorder of the mesenteric vasculature Patients with arterioportal fistula may present with complications, including portal hypertension (gastrointestinal bleeding and ascites), heart failure or intestinal ischemia. Furthermore, membranoproliferative glomerulonephritis (MPGN) subsequent to portosystemic shunts have been reported. In this paper, we report on a case of arterioportal fistula complicated with membranoproliferative glomerulonephritis and treated with an endovascular embolization procedure. A rapid improvement and complete resolution of ascites were observed following the treatment

Rivaroxaban Induces Mucosal Healing in a Rat Model of Trinitrobenzene Sulfonic Acid-Induced Colitis.

This study was designed to identify the effect of rivaroxaban, a direct factor Xa inhibitor, on trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats

The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with Familial Mediterranean Fever

Familial Mediterranean Fever (FMF) is an autosomal recessive disease characterized by periodic attacks of fever and polyserositis. The effects of the MEFV genotype differences on clinical picture and inflammatory activity have not been well documented. The aim of this study was to investigate levels of conventional inflammation markers, procalcitonin, interleukin levels, TNF-alpha, and C5a levels in patients with FMF who had different MEFV genotypes and compare them with those of healthy subjects. The study consisted of 41 patients with FMF (F/M: 23/18), and 31 healthy subjects (F/M: 18/13). Tests were performed during the attack-free period